Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Oxidative stress and oxidative damage in carcinogenesis.
Klaunig JE, Kamendulis LM, Hocevar BA. Klaunig JE, et al. Toxicol Pathol. 2010 Jan;38(1):96-109. doi: 10.1177/0192623309356453. Epub 2009 Dec 17. Toxicol Pathol. 2010. PMID: 20019356 Review.
Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance.
Klaunig JE, Hocevar BA, Kamendulis LM. Klaunig JE, et al. Among authors: hocevar ba. Reprod Toxicol. 2012 Jul;33(4):410-418. doi: 10.1016/j.reprotox.2011.10.014. Epub 2011 Nov 22. Reprod Toxicol. 2012. PMID: 22120428 Review.
Contribution of environment and genetics to pancreatic cancer susceptibility.
Hocevar BA, Kamendulis LM, Pu X, Perkins SM, Wang ZY, Johnston EL, DeWitt JM, Li L, Loehrer PJ, Klaunig JE, Chiorean EG. Hocevar BA, et al. PLoS One. 2014 Mar 20;9(3):e90052. doi: 10.1371/journal.pone.0090052. eCollection 2014. PLoS One. 2014. PMID: 24651674 Free PMC article.
Perfluorooctanoic acid exposure triggers oxidative stress in the mouse pancreas.
Kamendulis LM, Wu Q, Sandusky GE, Hocevar BA. Kamendulis LM, et al. Among authors: hocevar ba. Toxicol Rep. 2014 Aug 2;1:513-521. doi: 10.1016/j.toxrep.2014.07.015. eCollection 2014. Toxicol Rep. 2014. PMID: 28962265 Free PMC article.
The role of the folate pathway in pancreatic cancer risk.
Chittiboyina S, Chen Z, Chiorean EG, Kamendulis LM, Hocevar BA. Chittiboyina S, et al. Among authors: hocevar ba. PLoS One. 2018 Feb 23;13(2):e0193298. doi: 10.1371/journal.pone.0193298. eCollection 2018. PLoS One. 2018. PMID: 29474406 Free PMC article. Clinical Trial.
Perfluorooctanoic acid activates the unfolded protein response in pancreatic acinar cells.
Hocevar SE, Kamendulis LM, Hocevar BA. Hocevar SE, et al. Among authors: hocevar ba. J Biochem Mol Toxicol. 2020 Jun 24:e22561. doi: 10.1002/jbt.22561. Online ahead of print. J Biochem Mol Toxicol. 2020. PMID: 32578922
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
Gökmen-Polar Y, Toroni RA, Hocevar BA, Badve S, Zhao Q, Shen C, Bruckheimer E, Kinch MS, Miller KD. Gökmen-Polar Y, et al. Breast Cancer Res Treat. 2011 Jun;127(2):375-84. doi: 10.1007/s10549-010-1004-y. Epub 2010 Jul 3. Breast Cancer Res Treat. 2011. PMID: 20602165
Progression and treatment of HER2-positive breast cancer.
Davoli A, Hocevar BA, Brown TL. Davoli A, et al. Cancer Chemother Pharmacol. 2010 Mar;65(4):611-23. doi: 10.1007/s00280-009-1208-1. Epub 2009 Dec 20. Cancer Chemother Pharmacol. 2010. PMID: 20087739
Disabled-2 downregulation promotes epithelial-to-mesenchymal transition.
Martin JC, Herbert BS, Hocevar BA. Martin JC, et al. Among authors: hocevar ba. Br J Cancer. 2010 Nov 23;103(11):1716-23. doi: 10.1038/sj.bjc.6605975. Epub 2010 Nov 9. Br J Cancer. 2010. PMID: 21063401 Free PMC article.
29 results
Jump to page
Feedback